Grimes & Company’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-56
| Closed | -$23K | – | 307 |
|
|
2022
Q1 | $23K | Buy |
56
+14
| +33% | +$5.75K | ﹤0.01% | 299 |
|
|
2021
Q4 | $41K | Sell |
42
-8
| -16% | -$7.81K | ﹤0.01% | 297 |
|
|
2021
Q3 | $96K | Buy |
50
+5
| +11% | +$9.6K | ﹤0.01% | 295 |
|
|
2021
Q2 | $121K | Buy |
45
+19
| +73% | +$51.1K | 0.01% | 294 |
|
|
2021
Q1 | $107K | Buy |
26
+11
| +73% | +$45.3K | 0.01% | 272 |
|
|
2020
Q4 | $86K | Hold |
15
| – | – | ﹤0.01% | 260 |
|
|
2020
Q3 | $89K | Buy |
15
+4
| +36% | +$23.7K | 0.01% | 243 |
|
|
2020
Q2 | $59K | Buy |
11
+1
| +10% | +$5.36K | ﹤0.01% | 242 |
|
|
2020
Q1 | $37K | Hold |
10
| – | – | ﹤0.01% | 225 |
|
|
2019
Q4 | $50K | Buy |
+10
| New | +$50K | ﹤0.01% | 263 |
|